Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Natera, Inc. Director's Dealing 2018

Sep 13, 2018

30253_dirs_2018-09-13_3fb6051f-f875-4f4c-b81c-b54af483298f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Natera, Inc. (NTRA)
CIK: 0001604821
Period of Report: 2018-09-11

Reporting Person: Chapman Steven Leonard (Chief Operating Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-09-11 Common Stock M 13421 $2.6569 Acquired 16628 Direct
2018-09-11 Common Stock M 10225 $3.7816 Acquired 26853 Direct
2018-09-11 Common Stock M 5377 $7.4491 Acquired 32230 Direct
2018-09-11 Common Stock M 4474 $2.6569 Acquired 36704 Direct
2018-09-11 Common Stock M 11503 $3.7816 Acquired 48207 Direct
2018-09-11 Common Stock S 44500 $25.1548 Disposed 3707 Direct
2018-09-11 Common Stock S 500 $25.61 Disposed 3207 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-09-11 Stock Option (right to buy) $2.6569 M 13241 Disposed 2024-02-24 Common Stock (13421) Direct
2018-09-11 Stock Option (right to buy) $3.7816 M 10225 Disposed 2024-09-17 Common Stock (10225) Direct
2018-09-11 Stock Option (right to buy) $7.4491 M 5377 Disposed 2025-03-25 Common Stock (5377) Direct
2018-09-11 Stock Option (right to buy) $2.6569 M 4474 Disposed 2024-02-24 Common Stock (4474) Direct
2018-09-11 Stock Option (right to buy) $3.7816 M 11503 Disposed 2024-09-17 Common Stock (11503) Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2018.

F2: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.59 to $25.58 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The options are 100% vested and exercisable.

F4: The option shares vest over four years. 25% of the option shares vest and become exercisable on February 16, 2016 and the remaining shares vest in 36 equal monthly installments thereafter.